Cellectar Biosciences, Inc. (CLRB) - NASDAQ
From other sites
Company Description
Cellectar BioSciences, Inc. operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer. Its cancer-targeting technology permits selective delivery of a wide range of agents to cancer cells, including cancer stem cells. The company was... More
Sector: Healthcare
Industry: Biotechnology
Country: United States